Tumor-selective use of DNA base excision repair inhibition in pancreatic cancer using the NQO1 bioactivatable drug, β-lapachone

Gaurab Chakrabarti, Molly A. Silvers, Mariya Ilcheva, Yuliang Liu, Zachary R. Moore, Xiuquan Luo, Jinming Gao, Glenda Anderson, Lili Liu, Venetia Sarode, David E. Gerber, Sandeep Burma, Ralph J. DeBerardinis, Stanton L. Gerson, David A. Boothman

Research output: Contribution to journalArticlepeer-review

40 Scopus citations

Fingerprint Dive into the research topics of 'Tumor-selective use of DNA base excision repair inhibition in pancreatic cancer using the NQO1 bioactivatable drug, β-lapachone'. Together they form a unique fingerprint.

Medicine & Life Sciences